ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $605,000 | -27.5% | 97,347 | -29.4% | 0.07% | -16.0% |
| Q1 2017 | $834,000 | +284.3% | 137,824 | +240.5% | 0.08% | +170.0% |
| Q4 2016 | $217,000 | -85.0% | 40,477 | -84.7% | 0.03% | -84.4% |
| Q2 2016 | $1,449,000 | -65.0% | 263,878 | -52.7% | 0.19% | -61.6% |
| Q1 2016 | $4,142,000 | +397.2% | 558,204 | +457.1% | 0.50% | +380.8% |
| Q4 2015 | $833,000 | +54.0% | 100,194 | +67.0% | 0.10% | +40.5% |
| Q3 2015 | $541,000 | -30.8% | 60,000 | -8.0% | 0.07% | -44.4% |
| Q2 2015 | $782,000 | +134.8% | 65,200 | +110.6% | 0.13% | +49.4% |
| Q1 2015 | $333,000 | – | 30,956 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |